Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2012
11/01/2012CA2828483A1 Combination of kinase inhibitors and uses thereof
11/01/2012CA2827770A1 N-substituted oxazinopteridines and oxazinopteridinones
11/01/2012CA2826197A1 Pyrrolotriazinone derivatives as pi3k inhibitors
11/01/2012CA2819632A1 Vaginal composition based on alkyl polyglucosides
10/2012
10/31/2012EP2518150A2 5'Triphosphate oligonucleotide with blunt end and uses thereof
10/31/2012EP2518147A1 Diacylglycerole acyltranferase gene, and use thereof
10/31/2012EP2518144A1 Aging marker, method for evaluating aging inhibitor, and cancer inhibitor
10/31/2012EP2518074A1 Phosphoinositide 3-kinase inhibitor compounds and methods of use
10/31/2012EP2518073A1 Compounds for the treatment of Hepatitis C
10/31/2012EP2518072A1 Imidazopyridazine compounds
10/31/2012EP2518071A1 Imidazopyridine derivatives as PI3K inhibitors
10/31/2012EP2518070A1 Pyrrolotriazinone derivatives as PI3K inhibitors
10/31/2012EP2518067A1 Derivatives of N-[(1H-pyrazol-1-YL)aryl]-1H-indole or 1H- indazole-3-carboxamide and their therapeutic uses as P2Y12 antagonists
10/31/2012EP2518066A1 Novel anti-platelet agent
10/31/2012EP2518064A1 Novel aryl urea derivative
10/31/2012EP2518063A1 Pyridazinones and furan-containing compounds
10/31/2012EP2518060A1 Novel 3-hydroxy-5-arylisothiazole derivative
10/31/2012EP2518059A1 4-amino-1,3-thiazine or oxazine derivative
10/31/2012EP2518056A1 Seven-membered ring compound and pharmaceutical use therefor
10/31/2012EP2518054A1 Amide compound
10/31/2012EP2518052A1 Substituted 4-aminocyclohexane derivatives
10/31/2012EP2518049A2 Aminoalcohol derivatives and their therapeutic use
10/31/2012EP2517728A1 Drug for preventing or treating angiogenic eye diseases
10/31/2012EP2517722A2 Treatment of T-cell mediated diseases
10/31/2012EP2517721A2 Treatment of T-cell mediated diseases
10/31/2012EP2517719A1 Treatment of T-cell mediated diseases
10/31/2012EP2517718A2 Treatment of T-cell mediated diseases
10/31/2012EP2517717A1 Improved extration and purification method for cereal beta (1-3) beta (1-4) glucan
10/31/2012EP2517712A1 Composition for improving melasma and composition for reducing skin dullness
10/31/2012EP2517711A1 Hyperlipemia-ameliorating agent, anemia-ameliorating composition, uric-acid-level-reducing composition, and foods and beverages
10/31/2012EP2517710A1 Tamper-resistant oral opioid agonist formulations
10/31/2012EP2517709A1 Medical and pharmaceutical use of 2', 2-bis-thiazole non-nucleoside compounds as hepatitis c virus inhibitor
10/31/2012EP2517708A1 Method for predicting therapeutic effect of chemotherapy on hepatocellular carcinoma patient
10/31/2012EP2517707A1 Antitumor agent or postoperative adjuvant chemotherapeutic agent for treatment of hepatocellular carcinoma
10/31/2012EP2517706A2 Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof
10/31/2012EP2517705A1 Cubebin, dibenzylbutyrolactone lignan, semi-synthetic and synthetic derivatives thereof, and other lignans and neolignans as vasodilating agents in the therapy of erectile dysfunction
10/31/2012EP2517704A1 Pharmaceutical composition for treating parkinson's disease and preparation method thereof
10/31/2012EP2517703A1 Carnitine retention
10/31/2012EP2517702A1 Compounds, compositions and methods to treat skin diseases characterized by cellular proliferation and angiogenesis
10/31/2012EP2517701A1 Curing and prophylactic agent applied during the use of alcohol and psychoactive substances
10/31/2012EP2517700A1 Pharmaceutically acceptable cocrystals of N-[2-(7-methoxy-1-naphthyl]acetamide and methods of their preparation
10/31/2012EP2517699A1 Composition for prevention and treatment of arthritis
10/31/2012EP2517698A2 Agent for treating parkinson's disease
10/31/2012EP2517697A1 Combination composition useful for treating cardiovascular diseases
10/31/2012EP2517696A1 Extended release memantine tablet
10/31/2012EP2516648A2 Treatment of hepatocyte growth factor (hgf) related diseases by inhibition of natural antisense transcript to hgf
10/31/2012EP2516647A1 Molecule for treating an inflammatory disorder
10/31/2012EP2516646A2 Method of treatment and screening method
10/31/2012EP2516645A1 Influenza targets
10/31/2012EP2516628A1 Treatment of bone fracture
10/31/2012EP2516473A1 Anionic polysaccharides functionalised by a hydrophobic acid derivative
10/31/2012EP2516448A1 Amine salts of cefdinir
10/31/2012EP2516446A2 Substituted hexahydrochromeno[3,4-b]pyrroles with affinity for the serotonin receptor (5-ht) family
10/31/2012EP2516445A2 Tricyclic derivatives and their pharmaceutical use and compositions
10/31/2012EP2516444A2 Heterocyclic compounds as janus kinase inhibitors
10/31/2012EP2516442A1 Pyrrolo[2,3-d]pyrazin-7-yl pyrimidine compounds
10/31/2012EP2516441A1 Pteridinones as inhibitors of polo-like kinase
10/31/2012EP2516440A1 Bridgehead amine ring -fused indoles and indolines useful to treat neurodegenerative and neuropsychiatry disorders
10/31/2012EP2516439A1 Diaza-spiro[5.5]undecanes as orexin receptor antagonists
10/31/2012EP2516438A2 Compounds and methods for kinase modulation, and indications therefor
10/31/2012EP2516437A1 Disubstituted heteroaryl-fused pyridines
10/31/2012EP2516436A1 Imidazopyridine derivatives as jak inhibitors
10/31/2012EP2516435A1 Inhibitors of akt activity
10/31/2012EP2516434A1 Fused heteroaromatic pyrrolidinones as syk inhibitors
10/31/2012EP2516433A1 Substituted n-(1h-indazol-4-yl)imidazo[1, 2-a]pyridine-3- carboxamide compounds as cfms inhibitors
10/31/2012EP2516432A1 Methoxatin derivatives
10/31/2012EP2516431A1 Pyrrolopyridinyl-pyrimidin-2-ylamine derivatives
10/31/2012EP2516430A1 Fused tricyclic compounds and methods of use thereof for the treatment of viral diseases
10/31/2012EP2516429A1 Paxillin stimulating compositions and cosmetic uses thereof
10/31/2012EP2516428A1 Tropinone benzylamines as beta-tryptase inhibitors
10/31/2012EP2516426A1 Bis(difluormethyl)pyrazoles used as fungicides
10/31/2012EP2516425A1 Aminopyrimidine kinase inhibitors
10/31/2012EP2516422A1 Extracts from kibdelos porangium as antibacterial agents
10/31/2012EP2516420A1 Aminoalkylpyrimidine derivatives as histamine h4 receptor antagonists
10/31/2012EP2516419A1 Indolyl-piperidinyl benzylamines as beta-tryptase inhibitors
10/31/2012EP2516418A1 Prodrugs of [4[4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(1h-pyrrolo-pyridin-yl)-methanones and synthesis thereof
10/31/2012EP2516417A1 Isoindolinone inhibitors of phosphatidylinositol 3-kinase
10/31/2012EP2516416A1 Crth2 modulators
10/31/2012EP2516415A1 Carboxamide compounds and their use as calpain inhibitors iv
10/31/2012EP2516407A1 Radiopharmaceutical complexes
10/31/2012EP2516406A1 Mglu2 agonists
10/31/2012EP2516405A1 4-phenylamino-pyrimidine derivatives having protein kinase inhibitor activity
10/31/2012EP2516404A2 Preparation of bendamustine and its salts
10/31/2012EP2516400A1 Phenol derivatives and the pharmaceutical or cosmetic use thereof
10/31/2012EP2516399A1 Phenol derivatives and pharmaceutical or cosmetic use thereof
10/31/2012EP2516398A2 Novel phenol derivatives and pharmaceutical or cosmetic use thereof
10/31/2012EP2516397A1 Amino-heteroaryl derivatives as hcn blockers
10/31/2012EP2516396A1 Therapeutic compounds
10/31/2012EP2516395A1 (methylsulfonyl) ethyl benzene isoindoline derivatives and their therapeutical uses
10/31/2012EP2516393A1 Carboxamide compounds and their use as calpain inhibitors
10/31/2012EP2516392A1 Substituted benzamide derivatives
10/31/2012EP2516387A2 New inhibitors of cyclophilins and uses thereof
10/31/2012EP2516383A1 New aminotetraline derivatives
10/31/2012EP2516369A1 Process for preparing extra pure 2, 6-diisopropyl phenol
10/31/2012EP2516011A1 Carrier composition
10/31/2012EP2516010A2 Lipids, lipid compositions, and methods of using them
10/31/2012EP2516009A1 Substituted isoquinolinones and quinazolinones
10/31/2012EP2516008A1 Novel antiviral compounds
10/31/2012EP2515949A1 Aldehydes for in vivo imaging of aldh in cancer stem cells
10/31/2012EP2515947A2 Treatment of uncoupling protein 2 (ucp2) related diseases by inhibition of natural antisense transcript to ucp2
1 ... 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 ... 7860